| Patient | Elisabeth of Austria |
|---|---|
| Date of birth | 1969-12-24 |
| Identifiers | MRN HR-NI030-SYN; SSN (made up) 000-30-5817 |
| Document date | 2026-02-03 |
| Author | Adelheid Marchetti-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for new patient visit for weight loss, fatigue, ankle swelling and dizziness: history, examination with orthostatic vital signs, ECG, blood tests, depression and safety screening, a start to nutrition with thiamine, and an eating disorders psychiatry referral. [S]
Hemoglobin: 11.2 g/dL (low); MCV: 93 fL; White cell count: 3.4 10*3/uL (low); Platelets: 168 10*3/uL; Sodium: 136 mmol/L; Potassium: 3.6 mmol/L; Urea nitrogen: 21 mg/dL (high); Creatinine: 0.56 mg/dL (low); Glucose: 68 mg/dL (low); Magnesium: 1.8 mg/dL; Phosphate: 3 mg/dL; Albumin: 4.1 g/dL; ALT: 52 U/L (high); TSH: 2.2 mIU/L; CRP: 1 mg/L; Tissue transglutaminase IgA: 0.8 U/mL; Ferritin: 64 ng/mL; 25-hydroxyvitamin D: 22 ng/mL (low); QTc: 438 ms; eGFR: 107 mL/min/1.73 m²; PHQ-9: 16. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-02-03 | Body height | 172 | cm | S |
| 2026-02-03 | Body weight | 47.4 | kg | S |
| 2026-02-03 | Body mass index (BMI) [Ratio] | 16 | kg/m2 | S |
| 2026-02-03 | Systolic blood pressure | 96 | mm[Hg] | S |
| 2026-02-03 | Diastolic blood pressure | 62 | mm[Hg] | S |
| 2026-02-03 | Heart rate | 52 | /min | S |
| 2026-02-03 | Respiratory rate | 14 | /min | S |
| 2026-02-03 | Body temperature | 36 | Cel | S |
| 2026-02-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-02-03 | Hemoglobin [Mass/volume] in Blood | 11.2 | g/dL | 12-15.5 g/dL | Low | S |
| 2026-02-03 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 93 | fL | 80-100 fL | Normal | S |
| 2026-02-03 | Leukocytes [#/volume] in Blood by Automated count | 3.4 | 10*3/uL | 4-11 10*3/uL | Low | S |
| 2026-02-03 | Platelets [#/volume] in Blood by Automated count | 168 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-02-03 | Sodium [Moles/volume] in Serum or Plasma | 136 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-02-03 | Potassium [Moles/volume] in Serum or Plasma | 3.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-02-03 | Urea nitrogen [Mass/volume] in Serum or Plasma | 21 | mg/dL | 7-20 mg/dL | High | S |
| 2026-02-03 | Creatinine [Mass/volume] in Serum or Plasma | 0.56 | mg/dL | 0.59-1.04 mg/dL | Low | S |
| 2026-02-03 | Glucose [Mass/volume] in Serum or Plasma | 68 | mg/dL | 70-99 mg/dL | Low | S |
| 2026-02-03 | Magnesium [Mass/volume] in Serum or Plasma | 1.8 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 2026-02-03 | Phosphate [Mass/volume] in Serum or Plasma | 3 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 2026-02-03 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-02-03 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 52 | U/L | 7-35 U/L | High | S |
| 2026-02-03 | Thyrotropin [Units/volume] in Serum or Plasma | 2.2 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-02-03 | C reactive protein [Mass/volume] in Serum or Plasma | 1 | mg/L | <=5 mg/L | Normal | S |
| 2026-02-03 | Tissue transglutaminase IgA Ab [Units/volume] in Serum | 0.8 | U/mL | Below 4.0 is negative | Normal | S |
| 2026-02-03 | Ferritin [Mass/volume] in Serum or Plasma | 64 | ng/mL | 15-150 ng/mL | Normal | S |
| 2026-02-03 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 22 | ng/mL | 30-100 ng/mL | Low | S |
| 2026-02-03 | Q-T interval corrected | 438 | ms | Above 460 ms is prolonged in women | Normal | S |
| 2026-02-03 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 107 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 2026-02-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 16 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Thiamine 100 mg tablet, one by mouth daily for 14 days, starting before the meal plan | once daily for 14 days | Oral route | 2026-02-03 to 2026-02-17 | completed | S |
| Cholecalciferol 50 microgram (2,000 IU) capsule, one by mouth daily | once daily | Oral route | 2026-02-03 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Weight loss to a body mass index of 16.0 (47.4 kg at 172 cm), about 6 kg over six months, with fatigue, swelling of both ankles, dizziness on standing, slow pulse and cold intolerance; cause not established at intake; a restrictive eating disorder suspected, with thyroid disease, celiac disease, diabetes, malignancy and adrenal insufficiency to be excluded; eating disorders psychiatry consultation requested | active | confirmed | R63.4 | S — Synthetic presenting problem anchored to her documented restrictive eating, low weight and swelling; superseded by the diagnosis at the consultation. |
| Major depressive disorder, recurrent, moderate, with persistent grief for her son, who died five years ago; passive thoughts of death without intent or plan at intake | active | confirmed | F33.1 | S — Synthetic modern diagnosis linked to her documented mourning and ever-deepening depressions; not a claim that she was so diagnosed. |